Found 489 matching trials
Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies PHASE1 This is an investigator-initiated, multi-center, open-label clinical study ...
Show More Location
Multiple Locations
Learn More & Join Trial
Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients PHASE1 This first-in-human open-label, multi center, dose-escalation and expansion...
Show More Location
Liverpool Hospital
Learn More & Join Trial
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma PHASE1 The main purpose of this research study is to determine the maximum tolerab...
Show More Status
Active Not Recruiting
Location
University of Rochester
Learn More & Join Trial
A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma PHASE2 There is no standard treatment for chondrosarcoma. Some small sample of stu...
Show More Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Learn More & Join Trial
Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma PHASE2 Through open-label, single-center, randomised clinical trials, we intend to...
Show More Location
Multiple Locations
Learn More & Join Trial
Perioperative Therapy for Hepatocellular Carcinoma PHASE2 This study aims to observe and evaluate the efficacy and safety of the peri...
Show More Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C PHASE1 This trial is the cohort C part of a multicenter, open label Phase Ib/II cl...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC PHASE2 This study aims to observe and explore the efficacy and safety of Penpulima...
Show More Location
Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) PHASE2 This study is researching an investigational drug, called BNT116, in combin...
Show More Status
Active Not Recruiting
Location
The Oncology Institute of Hope and Innovation
Learn More & Join Trial
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors PHASE2 This is an open-label, single-arm, Phase II investigator-initiated trial of...
Show More Location
The Second Affiliated Hospital of SchoowUniversity
Learn More & Join Trial